Global Approved COVID-19 Vaccines Market Report, History and Forecast 2017-2028, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Approved COVID-19 Vaccines Market Overview
- 1.1 Approved COVID-19 Vaccines Product Overview
- 1.2 Approved COVID-19 Vaccines Market Segment by Type
- 1.2.1 Component Viral Vaccines
2 Global Approved COVID-19 Vaccines Market Competition by Company
- 2.1 Global Top Players by Approved COVID-19 Vaccines Sales (2017-2022)
- 2.2 Global Top Players by Approved COVID-19 Vaccines Revenue (2017-2022)
- 2.3 Global Top Players Approved COVID-19 Vaccines Price (2017-2022)
- 2.4 Global Top Manufacturers Approved COVID-19 Vaccines Manufacturing Base Distribution, Sales Area, Product Type
- 2.5 Approved COVID-19 Vaccines Market Competitive Situation and Trends
- 2.5.1 Approved COVID-19 Vaccines Market Concentration Rate (2017-2022)
3 Approved COVID-19 Vaccines Status and Outlook by Region
- 3.1 Global Approved COVID-19 Vaccines Market Size and CAGR by Region: 2017 VS 2021 VS 2028
- 3.2 Global Approved COVID-19 Vaccines Historic Market Size by Region
- 3.2.1 Global Approved COVID-19 Vaccines Sales in Volume by Region (2017-2022)
4 Global Approved COVID-19 Vaccines by Application
- 4.1 Approved COVID-19 Vaccines Market Segment by Application
- 4.1.1 Adults
5 North America Approved COVID-19 Vaccines by Country
- 5.1 North America Approved COVID-19 Vaccines Historic Market Size by Country
- 5.1.1 North America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
6 Europe Approved COVID-19 Vaccines by Country
- 6.1 Europe Approved COVID-19 Vaccines Historic Market Size by Country
- 6.1.1 Europe Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
7 Asia-Pacific Approved COVID-19 Vaccines by Region
- 7.1 Asia-Pacific Approved COVID-19 Vaccines Historic Market Size by Region
- 7.1.1 Asia-Pacific Approved COVID-19 Vaccines Sales in Volume by Region (2017-2022)
8 Latin America Approved COVID-19 Vaccines by Country
- 8.1 Latin America Approved COVID-19 Vaccines Historic Market Size by Country
- 8.1.1 Latin America Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
9 Middle East and Africa Approved COVID-19 Vaccines by Country
- 9.1 Middle East and Africa Approved COVID-19 Vaccines Historic Market Size by Country
- 9.1.1 Middle East and Africa Approved COVID-19 Vaccines Sales in Volume by Country (2017-2022)
10 Company Profiles and Key Figures in Approved COVID-19 Vaccines Business
- 10.1 Moderna
- 10.1.1 Moderna Corporation Information
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
- 11.1 Approved COVID-19 Vaccines Key Raw Materials
- 11.1.1 Key Raw Materials
12 Market Strategy Analysis, Distributors
- 12.1 Sales Channel
- 12.2 Approved COVID-19 Vaccines Distributors
- 12.3 Approved COVID-19 Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
Market Insights
Due to the COVID-19 pandemic, the global Approved COVID-19 Vaccines market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028.
The global main manufacturers of Approved COVID-19 Vaccines include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson&Johnson, Heat Biologics and Sanofi. etc. In 2021, the global six largest players have a share approximately % in terms of revenue.
The North America Approved COVID-19 Vaccines market is estimated at US$ million in 2021, while China is forecast to reach US$ million by 2028. The proportion of the China is % in 2021 and it is predicted that the share will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. As for the Europe Approved COVID-19 Vaccines landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Component Viral Vaccines accounting for % of the Approved COVID-19 Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Adults segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including sales and revenue forecast data by type and application for the period 2017-2028. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
Component Viral Vaccines
Whole Virus Vaccines
Segment by Application
Adults
Children
Elderly
Regional Scope
This segment of the report offers a thorough regional study of the global Approved COVID-19 Vaccines market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate, revenue, and sales volume according to the consumption for the period 2017-2028. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue and sales data of manufacturers for the period 2017-2022. Following is the list of key manufacturers observed in this research study:
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson&Johnson
Heat Biologics
Sanofi
Frequently Asked Questions
Which application segment captured the leading share in the Approved COVID-19 Vaccines market?
How fragmented is the Approved COVID-19 Vaccines market?
Which are the key growth drivers in the Approved COVID-19 Vaccines market?
Which are the top strategies undertaken by the Approved COVID-19 Vaccines market players?
Which technological trends are likely to affect the Approved COVID-19 Vaccines market?
What is the expected Approved COVID-19 Vaccines market size by 2028?
Which companies are dominating the Approved COVID-19 Vaccines market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Approved COVID-19 Vaccines market growth?
Which are the emerging companies in the Approved COVID-19 Vaccines market?